Blog - CADDAC

15/03/2017 - CADDAC National Director

CBC's Documentary “ADHD: Not Just for Kids”

On Thursday March the 16th at 8pm, CBC’s The Nature of Things will debut a documentary on Adult ADHD. The documentary “ADHD: Not Just for Kids” features adults sharing their storey of a lifelong struggle with ADHD symptoms and how they felt after recei

13/03/2017 - CADDAC National Director

CBC’s “Out in the Open” on Adult ADHD

This past Sunday CBC’s “Out in the Open” with Piya Chattopadhyay featured a great show on hidden disabilities including a segment on adult ADHD. Piya interviewed Russ LeBlanc, CADDAC’s communication/media consultant. Russ is our “go to guy” whenever w

23/02/2017 - CADDAC National Director

Study Looking at Brain Scans of Those with ADHD

Results of the largest ADHD brain imaging study of its kind was released this week in The Lancet Psychiatry. MRIs of 1713 people with ADHD were compared to a control group of 1529 people without ADHD, between the ages of 4 and 63, across 9 countries. S

09/02/2017 - Juanita Beaudry

Far Fewer Mental Health Medications are Recommended for Listing on Government Drug Plans When Compared to Non-mental Health Medications?

This very enlightening study questions how genuine our government’s call is for improved mental health treatment. While medication is only one treatment option, for many impacted by a mental health disorder, the right medication treatment can be life c

20/01/2017 - CADDAC National Director

Are we Prescribing too Many Antipsychotic Medications for Children with ADHD?

A recent study by the Institute for Clinical Evaluative Sciences found almost 12 per cent of children and youth with attention deficit hyperactivity disorder, or ADHD, were prescribed antipsychotics like Risperdal, Zyprexa and Seroquel. Since the study

23/12/2016 - Juanita Beaudry

New BC PharmaCare Coverage Discriminatory to Adults with ADHD

New BC PharmaCare Coverage Discriminatory to Adults with ADHD On April 18th BC PharmaCare announced that it was expanding its existing coverage of medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the paediatric popula